NM_032273.4:c.395+10A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032273.4(TMEM126A):​c.395+10A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.238 in 1,593,950 control chromosomes in the GnomAD database, including 50,401 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6837 hom., cov: 33)
Exomes 𝑓: 0.23 ( 43564 hom. )

Consequence

TMEM126A
NM_032273.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.0600

Publications

19 publications found
Variant links:
Genes affected
TMEM126A (HGNC:25382): (transmembrane protein 126A) The protein encoded by this gene is a mitochondrial membrane protein of unknown function. Defects in this gene are a cause of optic atrophy type 7 (OPA7). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
TMEM126A Gene-Disease associations (from GenCC):
  • optic atrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • autosomal recessive optic atrophy, OPA7 type
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 11-85655718-A-G is Benign according to our data. Variant chr11-85655718-A-G is described in ClinVar as Benign. ClinVar VariationId is 262022.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.393 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM126ANM_032273.4 linkc.395+10A>G intron_variant Intron 4 of 4 ENST00000304511.7 NP_115649.1 Q9H061-1
TMEM126ANM_001244735.2 linkc.185+10A>G intron_variant Intron 3 of 3 NP_001231664.1 Q9H061-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM126AENST00000304511.7 linkc.395+10A>G intron_variant Intron 4 of 4 1 NM_032273.4 ENSP00000306887.2 Q9H061-1

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43388
AN:
151912
Hom.:
6796
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.398
Gnomad AMI
AF:
0.173
Gnomad AMR
AF:
0.327
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.390
Gnomad SAS
AF:
0.398
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.272
GnomAD2 exomes
AF:
0.290
AC:
72759
AN:
251040
AF XY:
0.284
show subpopulations
Gnomad AFR exome
AF:
0.398
Gnomad AMR exome
AF:
0.428
Gnomad ASJ exome
AF:
0.244
Gnomad EAS exome
AF:
0.374
Gnomad FIN exome
AF:
0.274
Gnomad NFE exome
AF:
0.200
Gnomad OTH exome
AF:
0.261
GnomAD4 exome
AF:
0.233
AC:
336366
AN:
1441918
Hom.:
43564
Cov.:
26
AF XY:
0.237
AC XY:
170121
AN XY:
718714
show subpopulations
African (AFR)
AF:
0.398
AC:
13173
AN:
33088
American (AMR)
AF:
0.418
AC:
18684
AN:
44658
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
6339
AN:
25986
East Asian (EAS)
AF:
0.395
AC:
15625
AN:
39518
South Asian (SAS)
AF:
0.384
AC:
32937
AN:
85812
European-Finnish (FIN)
AF:
0.269
AC:
14364
AN:
53372
Middle Eastern (MID)
AF:
0.224
AC:
1282
AN:
5722
European-Non Finnish (NFE)
AF:
0.200
AC:
218947
AN:
1094066
Other (OTH)
AF:
0.252
AC:
15015
AN:
59696
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
11969
23937
35906
47874
59843
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8026
16052
24078
32104
40130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.286
AC:
43487
AN:
152032
Hom.:
6837
Cov.:
33
AF XY:
0.294
AC XY:
21863
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.398
AC:
16512
AN:
41442
American (AMR)
AF:
0.328
AC:
5007
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
812
AN:
3468
East Asian (EAS)
AF:
0.389
AC:
2016
AN:
5176
South Asian (SAS)
AF:
0.397
AC:
1919
AN:
4828
European-Finnish (FIN)
AF:
0.268
AC:
2832
AN:
10574
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13593
AN:
67948
Other (OTH)
AF:
0.273
AC:
577
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1524
3048
4573
6097
7621
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.253
Hom.:
1829
Bravo
AF:
0.296
Asia WGS
AF:
0.419
AC:
1457
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 19, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive optic atrophy, OPA7 type Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.6
DANN
Benign
0.74
PhyloP100
0.060
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2196168; hg19: chr11-85366762; COSMIC: COSV52629142; COSMIC: COSV52629142; API